publication date: Nov. 22, 2019

Clinical Roundup

Care in a multidisciplinary prostate cancer clinic increases discussion of treatment options, adherence to guidelines

Men who seek treatment at a multidisciplinary prostate cancer clinic are more likely to be advised about treatment choices and to receive care that complies with evidence-based treatment guidelines, an MD Anderson Cancer Center study found.

African American men who visited the MultiD clinic also were more likely to receive definitive, or curative, therapy, compared with national trends.

The findings, published in Cancer, are based on the largest and longest analysis of a MultiD clinic database. The study evaluated treatment choice at MD Anderson’s Multidisciplinary Prostate Cancer Clinic in comparison to U.S. national trends assessed by reviewing the SEER database.

“Men who visit a MultiD prostate clinic have the opportunity to see a radiation oncologist and a urologist in the same visit, giving them the chance to discuss treatments options and potential side effects in order to make an informed treatment decision,” Chad Tang, assistant professor of Radiation Oncology and lead author, said in a statement. “Patients and their families appreciate the opportunity to hear all treatment options and receive assistance with decision-making.”

The study analyzed 4,451 men with prostate cancer treated at the MultiD clinic from 2004-2016. To compare nationwide trends, 392,710 men with prostate cancer diagnosed from 2004-2015 were selected from the SEER database.

Men with low-risk disease were more likely to choose active surveillance in the MultiD clinic than the SEER group. In 2015, the rate of active surveillance among men with low-risk disease in the MultiD clinic was 74% compared with 54% in the SEER group. The tendency toward active surveillance for patients with low-risk prostate cancer is supported … Continue reading Care in a multidisciplinary prostate cancer clinic increases discussion of treatment options, adherence to guidelines

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.